This is with reference to the email communication received from BSE Limited on April 09,2026 seeking clarification for a significant movement in the price of the securities of the company.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
BSE had written to ANG Lifesciences on April 9, 2026, asking the company to explain a significant movement in the price of its shares. In its reply dated April 10, 2026, the company stated that there is no undisclosed price-sensitive information or announcement under SEBI Listing Regulations that could explain the movement. The company said the price change is purely market-driven and beyond its control. It also confirmed that it has been disclosing all required information to the exchange on a regular basis.
This is a standard 'no material info' clarification, so there is no direct fundamental trigger for the price move. Investors should note that the exchange is watching the stock, but no negative disclosure has been made, which is mildly reassuring in the short term.